Insulin action and hepatic glucose cycling in essential hypertension. 1992

D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
Sir George E. Clark Metabolic Unit, Royal Victoria Hospital, Belfast, Northern Ireland.

Peripheral insulin resistance is a feature of essential hypertension, but there is little information about hepatic insulin sensitivity. To investigate peripheral and hepatic insulin sensitivity and activity of the hepatic glucose/glucose 6-phosphate (G/G6P) substrate cycle in essential hypertension, euglycemic glucose clamps were performed in eight untreated patients and eight matched controls at insulin infusion rates of 0.2 and 1.0 mU.kg-1.min-1. A simultaneous infusion of (2(3)H)- and (6(3)H)glucose, combined with a selective detritiation procedure, was used to determine glucose turnover, the difference being G/G6P cycle activity. Endogenous hepatic glucose production (EGP) determined with (6(3)H)glucose was similar in hypertensive and control groups in the postabsorptive state (11.0 +/- 0.3 v 10.9 +/- 0.3 mumol.kg-1.min-1) and with the 0.2 mU insulin infusion (4.9 +/- 0.5 v 4.0 +/- 0.8 mumol.kg-1.min-1). With the 1.0 mU insulin infusion, glucose disappearance determined with (6(3)H)glucose was lower in the hypertensive group (21.8 +/- 2.4 v 29.9 +/- 2.4 mumol.kg-1.min-1, P less than .001). G/G6P cycle activity was similar both in the postabsorptive state (2.2 +/- 0.4 v 2.7 +/- 0.4 mumol.kg-1.min-1) and during insulin infusion (0.2 mU, 2.5 +/- 0.3 v 2.9 +/- 0.4; 1.0 mU, 4.7 +/- 0.3 v 5.3 +/- 1.1 mumol.kg-1.min-1 for hypertensive and control groups, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011773 Pyruvates Derivatives of PYRUVIC ACID, including its salts and esters.
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference

Related Publications

D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
June 1997, Clinical endocrinology,
D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
August 1995, The Journal of clinical investigation,
D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
May 1993, Hypertension (Dallas, Tex. : 1979),
D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
August 1994, Metabolism: clinical and experimental,
D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
September 1994, Clinical and experimental hypertension (New York, N.Y. : 1993),
D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
July 1981, Polskie Archiwum Medycyny Wewnetrznej,
D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
September 1991, Hypertension (Dallas, Tex. : 1979),
D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
April 2006, Cell metabolism,
D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
February 1991, Hypertension (Dallas, Tex. : 1979),
D P Rooney, and R D Neely, and C N Ennis, and N P Bell, and B Sheridan, and A B Atkinson, and E R Trimble, and P M Bell
March 1999, American journal of hypertension,
Copied contents to your clipboard!